IP Library Granted Patent US 9,518,131
Granted Patent B2
US 9,518,131 · App. 14/242,725 · Granted Dec 13, 2016

Generating metal ion binding proteins

Inventors: Holger Thie (Cologne, DE); Kristina Reck (Kurten, DE); Volker Nolle (Kurten, DE)
Assignee: Miltenyi Biotech GmbH
C07K16/44C07K16/2815C07K2317/515C07K2317/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,518,131
App. No.
14/242,725
Granted
Dec 13, 2016
Kind
B2
Abstract

The present invention provides for a method for generating a metal ion binding protein, the method comprising a) integrating the amino acid sequence DDD into CDR1 of a light chain variable region of an antibody or fragment thereof; and b) combining the sequence of step a) with a heavy chain variable region of an antibody or fragment thereof; and c) isolating the protein. Also provided is the use of metal ion binding proteins generated by the method of the present invention for isolation and purification of proteins and for the reversible labeling of a target molecule. Also provided is a metal ion binding anti-CD8 protein.

Claims (3)

1. A method for the targeted generation of antibodies or fragments thereof that bind antigen in a Ca2+ or Mg2+ dependent manner, the method comprising: a) combining SEQ ID No: 1 or a fragment comprising the CDRs of SEQ ID NO: 1 with antibody heavy chain variable regions; b) screening for antibodies that bind antigen in a Ca2+ or Mg2+ dependent manner; and c) identifying individual antibodies or antigen binding fragments thereof that bind antigen in a Ca2+ or Mg2+ dependent manner.

2. The method of claim 1 , wherein said step b) is performed by a method selected from the group consisting of high-throughput ELISA screening, high-throughput cell-based screening, phage display selection, and yeast display selection.

3. The method of claim 1 , wherein said step c) is performed by ELISA or flow cytometry.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2019
From: MILTENYI BIOTEC GMBH
To: MILTENYI BIOTEC B.V. & CO. KG
Reel/Frame 051443/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2014
From: THIE, HOLGER; RECK, KRISTINA; NOLLE, VOLKER
To: MILTENYI BIOTECH GMBH
Reel/Frame 033280/0085 →
Priority Claims (1)
EM 13161984 · Apr 2, 2013 · regional
Continuity (1)
Related Publication 20140296491A1 · Oct 2, 2014